Skip to content
Home/Companies/Biotech/Opthea
OP

Opthea

Biotech·Australia·Active·4yr hold

Opthea is a biotech company, headquartered in Australia.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Opthea?

Opthea is currently owned by Abingworth through Abingworth Clinical Co-Development Fund 2 (2021 vintage), since 2022.

Hand-verified · updated 2026-07-08

Abingworth
Investor
Abingworth
Abingworth Clinical Co-Development Fund 2 · 2021 · Life Sciences VC

Key facts

HQAustralia
SectorBiotech
StatusActive

More from Abingworth Clinical Co-Development Fund 2

Other portfolio companies in the same fund.

Launch Therapeutics
Active
BiotechUS· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings